“La aprobación de la OMS llegará en breve”, dijo a Infobae el desarrollador de la vacuna Sputnik
El Director Ejecutivo del Fondo Ruso de Inversión Directa (RDIF), Kirill Dmitriev, aseguró que están “en buenas negociaciones” con el organismo. Adelantó que la fórmula rusa sería eficaz contra la variante Ómicron
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/TL4X3A4HGNCFZKTUJJ6M3OAOVQ.jpg 80w){kind=small}
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/MGULLUG2LG5FNHD566UDA5HSYI.jpg 80w){kind=small}
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/JPKMH4BNEESPYVH4PYNHXUYUHA.jpg 80w){kind=small}
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/3XWCV4COYJB5HFNITQ3M4ED3UY 80w){kind=small}
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/YIAFMJP65IHGHSQQV32TA5UFZU.jpg 80w){kind=small}
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/GIIMOA5TYDYYDPYDC2N2J5AM4U.jpg 80w){kind=small}
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/DR7X3ZKXKL5ZRRG3GJLOGDFW34.jpg 80w){kind=small}
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/G65FNGEFONFRXE2T5OK6YGK3NU.jpg 80w){kind=small}
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/IW52YZLCFZ6ULA37QMLKQUMB6Q.jpg 80w){kind=small}